The reported statements, read against the company's own industry.
Financials view
Market Capitalization
1.95BCNY
292.03M · vs all stocks (USD)
Updated Oct 24, 2026
Revenue (TTM)
203.76MCNY
30.56M · vs all stocks (USD)
Updated Oct 24, 2026
Profit Margin
-43.50%
vs Scientific & Technical Instruments peers
Updated Oct 24, 2026
Beta
-0.0480x
vs all stocks
Updated Oct 24, 2026
52-Week Change
2.93%
vs all stocks
Updated Oct 24, 2026
Market Capitalization
1.95BCNY
292.03M · vs all stocks (USD)
Updated Oct 24, 2026
Enterprise Value
1.92BCNY
288.23M · vs all stocks (USD)
Updated Oct 24, 2026
Price to Sales (TTM)
8.81x
vs Scientific & Technical Instruments peers
Provider-reported. Market Capitalization ÷ Revenue (TTM) on this page gives 9.56×.Updated Oct 24, 2026
Price to Book (MRQ)
4.63x
vs Scientific & Technical Instruments peers
Updated Oct 24, 2026
Enterprise to Revenue
9.43x
vs Scientific & Technical Instruments peers
Updated Oct 24, 2026
Enterprise to EBITDA
-23.92x
vs Scientific & Technical Instruments peers
Updated Oct 24, 2026
Gross Margin
42.08%
vs Scientific & Technical Instruments peers
Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 28.25%.Updated Oct 24, 2026
Profit Margin
-43.50%
vs Scientific & Technical Instruments peers
Updated Oct 24, 2026
Operating Margin
-21.68%
vs Scientific & Technical Instruments peers
Updated Oct 24, 2026
Return on Assets (TTM)
-7.72%
vs Scientific & Technical Instruments peers
Updated Oct 24, 2026
Return on Equity (TTM)
-20.66%
vs Scientific & Technical Instruments peers
Updated Oct 24, 2026
Revenue (TTM)
203.76MCNY
30.56M · vs all stocks (USD)
Updated Oct 24, 2026
Revenue per Share (TTM)
2.70CNYUpdated Oct 24, 2026
Quarterly Revenue Growth
-8.80%
vs Scientific & Technical Instruments peers
Updated Oct 24, 2026
Gross Profit (TTM)
57.56MCNY
8.63M · vs all stocks (USD)
Updated Oct 24, 2026
EBITDA (TTM)
-80.34MCNY
-12.05M · vs all stocks (USD)
Updated Oct 24, 2026
Net Income (TTM)
-88.64MCNY
-13.29M · vs all stocks (USD)
Updated Oct 24, 2026
Quarterly Earnings Growth (YoY)
-8.84%
vs Scientific & Technical Instruments peers
Updated Oct 24, 2026
Operating Cash Flow (TTM)
-29.99MCNY
-4.50M · vs all stocks (USD)
Updated Oct 24, 2026
Levered Free Cash Flow (TTM)
-63.36MCNY
-9.50M · vs all stocks (USD)
Updated Oct 24, 2026
Payout Ratio
0.00%
vs Scientific & Technical Instruments peers
Updated Oct 24, 2026
Minority Interest (Equity)
-111.87KCNYFY2025 · Dec 31, 2025
Revenue
210.14MCNYFY2025 · Dec 31, 2025
Cost of Goods Sold
130.70MCNYFY2025 · Dec 31, 2025
Gross Profit
79.44MCNYFY2025 · Dec 31, 2025
Operating Income
-40.97MCNY
-6.15M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
-84.33MCNYFY2025 · Dec 31, 2025
Income Tax Expense
-1.92MCNYFY2025 · Dec 31, 2025
Net Income
-82.41MCNYFY2025 · Dec 31, 2025
EBIT
-79.94MCNYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
-22.00MCNYFY2025 · Dec 31, 2025
Research & Development
62.14MCNYFY2025 · Dec 31, 2025
Selling, General & Administrative
22.92MCNYFY2025 · Dec 31, 2025
Other Operating Expenses
873.75KCNYFY2025 · Dec 31, 2025
Non-operating Interest Income
1.59MCNYFY2025 · Dec 31, 2025
Non-operating Interest Expense
4.39MCNYFY2025 · Dec 31, 2025
EPS (Basic)
-1.08CNYFY2025 · Dec 31, 2025
EPS (Diluted)
-1.08CNYFY2025 · Dec 31, 2025
Basic Shares Outstanding
76.20MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
76.20MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
-82.41MCNYFY2025 · Dec 31, 2025
Minority Interests (P&L)
111.87KCNYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025
Operating Cash Flow
-103.37MCNYFY2025 · Dec 31, 2025
Free Cash Flow
-124.05MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
170.48MCNYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
-82.41MCNYFY2025 · Dec 31, 2025
Other Non-cash Items
7.33MCNYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
4.91MCNYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
-33.20MCNYFY2025 · Dec 31, 2025
Capital Expenditures
-20.68MCNYFY2025 · Dec 31, 2025
Other Investing Activity
-6.95MCNYFY2025 · Dec 31, 2025
Net Investing Cash Flow
-27.63MCNYFY2025 · Dec 31, 2025
Long-term Debt Issuance
139.76MCNYFY2025 · Dec 31, 2025
Long-term Debt Payments
-60.00MCNYFY2025 · Dec 31, 2025
Common Dividends Paid
-3.06MCNYFY2025 · Dec 31, 2025
Other Financing Charges
-19.63MCNYFY2025 · Dec 31, 2025
Net Financing Cash Flow
57.07MCNYFY2025 · Dec 31, 2025
Shares Outstanding
76.00MSharesUpdated Oct 24, 2026
Float Shares
37.40MSharesUpdated Oct 24, 2026
% Held by Insiders
45.26%
vs all stocks
Updated Oct 24, 2026
% Held by Institutions
13.00%
vs all stocks
Updated Oct 24, 2026
Total Cash (MRQ)
148.24MCNY
22.23M · vs all stocks (USD)
Updated Oct 24, 2026
Total Cash per Share (MRQ)
1.96CNYUpdated Oct 24, 2026
Total Debt (MRQ)
189.74MCNY
28.46M · vs all stocks (USD)
Updated Oct 24, 2026
Total Debt to Equity (MRQ)
0.4924x
vs Scientific & Technical Instruments peers
Updated Oct 24, 2026
Current Ratio (MRQ)
1.95x
vs Scientific & Technical Instruments peers
Updated Oct 24, 2026
Book Value per Share (MRQ)
5.10CNYUpdated Oct 24, 2026
Total Assets
708.25MCNY
106.22M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
575.96MCNYFY2025 · Dec 31, 2025
Total Liabilities
296.36MCNYFY2025 · Dec 31, 2025
Total Non-current Assets
132.28MCNYFY2025 · Dec 31, 2025
Total Non-current Liabilities
29.96MCNYFY2025 · Dec 31, 2025
Total Current Liabilities
266.40MCNYFY2025 · Dec 31, 2025
Cash
170.48MCNYFY2025 · Dec 31, 2025
Cash Equivalents
16.70MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
187.18MCNYFY2025 · Dec 31, 2025
Accounts Receivable
188.37MCNYFY2025 · Dec 31, 2025
Inventory
169.42MCNYFY2025 · Dec 31, 2025
Accounts Payable
96.29MCNYFY2025 · Dec 31, 2025
Short-term Debt
151.80MCNYFY2025 · Dec 31, 2025
Other Current Liabilities
1.00MCNYFY2025 · Dec 31, 2025
Long-term Debt
29.95MCNYFY2025 · Dec 31, 2025
Common Stock (Book)
76.00MCNYFY2025 · Dec 31, 2025
Retained Earnings
-148.31MCNYFY2025 · Dec 31, 2025
Total Shareholders' Equity
411.89MCNY
61.78M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Treasury Stock
10.46MCNYFY2025 · Dec 31, 2025
52-Week Low
22.02CNYUpdated Oct 24, 2026
52-Week High
56.50CNYUpdated Oct 24, 2026
52-Week Change
2.93%
vs all stocks
Updated Oct 24, 2026
Beta
-0.0480x
vs all stocks
Updated Oct 24, 2026
50-Day MA
28.15CNYUpdated Oct 24, 2026
200-Day MA
34.01CNYUpdated Oct 24, 2026
Avg 10-Day Volume
1.47MSharesUpdated Oct 24, 2026
Avg 30-Day Volume
1.34MSharesUpdated Oct 24, 2026
Diluted EPS (TTM)
-1.09CNYUpdated Oct 24, 2026
2 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
The price is falling, swinging wider than usual, and sits well below its peak.
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Operating margin is -21.7%, lower than 95% of its Scientific & Technical Instruments peers (median 9%)Significant